Skip to Main Content

Paper Details

TET2-mutant clonal hematopoiesis and risk of gout.
Blood
44
2022
CHIP, Clonal hematopoiesis of indeterminate potential, Gout, IL-1, MSU, NLRP3, Nlrp3 inflammasome, TET2, Tet2, Tet2 knockout hematopoietic cells, Tet2 knockout macrophages, VAF, cardiovascular disease, gout, hematologic cancers, humans, hyperuricemia, inflammatory arthritis, interleukin-1, monosodium urate, murine, patients, paw edema, variant
Author NameAffiliation
Abhishek NiroulaDana-Farber Cancer Institute
Abhishek NiroulaLund University
Abhishek NiroulaBroad Institute of Harvard and MIT
Christopher J GibsonDana-Farber Cancer Institute
Donna NeubergDana-Farber Cancer Institute
Richard M StoneDana-Farber Cancer Institute
Alexander G BickVanderbilt University Medical Center
Siddhartha JaiswalDepartment of Pathology and Institute for Stem Cell Biology and Regenerative Medicine, Stanford University School of Medicine
Pradeep NatarajanCardiovascular Research Center, Massachusetts General Hospital
Pradeep NatarajanBroad Institute of Harvard and MIT
Pradeep NatarajanHarvard Medical School
Benjamin L EbertDana-Farber Cancer Institute
Benjamin L EbertHoward Hughes Medical Institute
  • 1 - 13

Datasets

Release 1.2